サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390829

犬アトピー性皮膚炎市場：世界の産業動向、シェア、規模、成長、機会、2023年～2028年予測

Canine Atopic Dermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
犬アトピー性皮膚炎市場：世界の産業動向、シェア、規模、成長、機会、2023年～2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

犬アトピー性皮膚炎の世界市場規模は2022年に18億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに44億米ドルに達し、2022年から2028年の間に16.06%の成長率（CAGR）を示すと予測しています。

犬アトピー性皮膚炎（CAD）は、花粉、ハウスダスト、虫刺され、牧草、食物成分などのアレルゲンによって引き起こされる犬のアレルギー性皮膚疾患です。遺伝性素因があり、一般的に生後6ヵ月から3歳の犬が罹患します。一般的に腹部、口、目、趾間皮膚、耳介、手根、肘、会陰部などに発症します。CADは、前足、脇の下、顔の周りの過剰な掻破、炎症、痒みなどの様々な症状を特徴とします。免疫抑制剤、モノクローナルアナトミー、グルココルチコイドで治療することができます。これらは内服薬、注射薬、外用薬によって投与されます。ジャーマン・シェパード、ラブラドール、ゴールデン・レトリーバー、パグに多く見られることが知られています。

犬アトピー性皮膚炎の市場動向：

世界中で飼い犬におけるCADの発生が増加していることは、市場に明るい展望をもたらす重要な要因の一つです。これは、環境条件の変化、大気汚染レベルの上昇、アレルゲンへの長時間の曝露に起因しています。さらに、赤み、脂っぽい皮膚、酵母のような臭いなど、CADの初期症状や兆候に対する飼い主の関心の高まりや意識の向上が、市場の成長を後押ししています。さらに、この病気の治療にモノクローナル抗体が広く採用されていることも、市場の成長を後押ししています。これらの抗体は、必要な免疫反応を誘導し、病気の蔓延を沈静化するのに役立ちます。これに伴い、動物のためのより良いケアを提供することに専念する獣医開業医、病院、診療所の数が増加していることが、市場成長にプラスの影響を与えています。その他にも、動物に対する適応外の人間用医薬品の使用を制限するための様々な政府イニシアチブの実施や、獣医学分野における広範な研究開発（R&D）などが、市場の成長を促進すると予測されています。

本レポートで扱う主な質問

  • 犬アトピー性皮膚炎の世界市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が世界の犬アトピー性皮膚炎市場に与えた影響は？
  • 主要な地域市場は？
  • 薬剤クラス別の市場内訳は？
  • 投与経路別の市場内訳は？
  • 販売チャネル別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の犬アトピー性皮膚炎市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 犬アトピー性皮膚炎の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：薬剤クラス別

  • グルココルチコイド
    • 市場動向
    • 市場予測
  • 免疫抑制剤
    • 市場動向
    • 市場予測
  • モノクローナル抗体
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：投与経路別

  • 外用剤
    • 市場動向
    • 市場予測
  • 経口剤
    • 市場動向
    • 市場予測
  • 注射剤
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 動物病院
    • 市場動向
    • 市場予測
  • ペットクリニック
    • 市場動向
    • 市場予測
  • 薬局・ドラッグストア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AB Science
    • Bimeda Inc.
    • Bioceltix SA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Phibro Animal Health Corporation
    • Toray Industries Inc.
    • Vetoquinol S.A.
    • Virbac
    • Zoetis Inc.
図表

List of Figures

  • Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2022
  • Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
  • Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
  • Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million US$), 2023-2028
  • Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
  • Table 7: Global: Canine Atopic Dermatitis Market: Key Players
目次
Product Code: SR112023A4700

Abstract

The global canine atopic dermatitis market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.06% during 2022-2028.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class type, route of administration and distribution channel.

Breakup by Drug Class Type:

Glucocorticoids

Immunosuppressants

Monoclonal Antibody

Others

Breakup by Route of Administration:

Topical

Oral

Injectable

Breakup by Distribution Channel:

Veterinary Hospitals

Pet Clinics

Pharmacies and Drugstores

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global canine atopic dermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global canine atopic dermatitis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Canine Atopic Dermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class Type

  • 6.1 Glucocorticoids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Monoclonal Antibody
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Injectable
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pet Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pharmacies and Drugstores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AB Science
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Bimeda Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bioceltix SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Ceva Sante Animale
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Dechra Pharmaceuticals PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Elanco Animal Health Incorporated
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Phibro Animal Health Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Toray Industries Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vetoquinol S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis